리메드

302550KOSDAQ의료용 기기 제조업

39.0 / 100

Reference Date: 2026-07-24

Financial Score10.5 / 40

News Sentiment12.5 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE is below the industry average, PER raises overvaluation concerns. Slightly up 5.0% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Remed is a company specializing in developing and manufacturing medical devices that utilize non-invasive magnetic stimulation technology to treat various conditions such as depression, stroke, and chronic pain. Its key products, BrainStim and ALTMS, have received FDA and KFDA certifications for depression treatment and are expanding globally. The company also offers chronic pain management through NMS and aesthetic services via CSMS.

Number of Employees

114people

Average Salary

46.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

160.88Industry Average 20.040.0Point

8.0x industry avg (risky)

PBR

2.14Industry Average 1.141.0Point

1.9x industry avg (risky)

ROE

-0.09Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

12.60Industry Average 11.652.0Point

Higher than industry avg (caution)

Trend 2023~20257.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲16.9% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲52.0% (2-year basis)

ROE Trend

2.0 / 4

Avg ROE 7.2% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (15%, downtrend)

Current 2,735Won52-week high 3,98552-week low 2,500

1-month return4.0Point

1m +4.99% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral주식소각결정2026-07-23
Neutral[기재정정]사업보고서 (2025.12)2026-06-26